Boarescu Ioana, Boarescu Paul-Mihai
Neurology Department, Clinical Emergency County Hospital Saint John the New, 720229 Suceava, Romania.
Cardiology Departement, Clinical Emergency County Hospital Saint John the New, 720229 Suceava, Romania.
J Cardiovasc Dev Dis. 2024 Dec 18;11(12):406. doi: 10.3390/jcdd11120406.
Myocardial infarction (MI) is a significant cardiovascular event caused by the decrease in or complete cessation of blood flow to a portion of the myocardium. It can arise from a variety of etiological factors, including pharmacological triggers. This review aims to explore the diverse drugs and substances that might lead to drug-induced myocardial infarction, focusing on their mechanisms of action and the pathophysiological processes involved. Various established and emerging pharmacological agents that could elevate the risk of myocardial infarction, such as nonsteroidal anti-inflammatory drugs, hormonal therapies, anticoagulants, and antipsychotic medications, are discussed. The role of drug-induced endothelial dysfunction, coronary artery spasm, and thrombosis are presented in order to highlight the underlying mechanisms. This review emphasizes the need for increased awareness among healthcare professionals to mitigate the risks associated with different pharmacological therapies to improve patient outcomes.
心肌梗死(MI)是一种由心肌某部分血流减少或完全中断引起的重大心血管事件。它可由多种病因引起,包括药物触发因素。本综述旨在探讨可能导致药物性心肌梗死的各种药物和物质,重点关注其作用机制和涉及的病理生理过程。讨论了各种已确定和新出现的可能增加心肌梗死风险的药物,如非甾体抗炎药、激素疗法、抗凝剂和抗精神病药物。还介绍了药物性内皮功能障碍、冠状动脉痉挛和血栓形成的作用,以突出其潜在机制。本综述强调医疗保健专业人员需要提高认识,以降低与不同药物治疗相关的风险,从而改善患者预后。